California-Based Meduloc Scores $4M in Series B Funding

Meduloc, a West Chester, PA-based orthopedic medical device company, has raised $4 million in a Series B funding round led by GenHenn Capital.

The round also saw participation from Life Sciences Greenhouse Investments (LSGI), Ben Franklin Technology Partners of Southeastern Pennsylvania, Broad Street Angels and former Los Angeles Dodgers player Andre Ethier, together with additional existing and new investors.

The fresh capital will help Meduloc begin its controlled alpha launch, generate additional clinical evidence and build the commercial infrastructure needed to bring its fracture fixation technology to orthopedic surgeons and patients.

Funding Snapshot

About Meduloc

Founded as an orthopedic medical device company, Meduloc is focused on improving fracture fixation through a flexible nitinol intramedullary platform.

Its FDA-cleared, sterile and single-use system is designed to provide fracture stability while preserving anatomy and avoiding joint violation in certain applications.

Read More:Deeptech Company Mitti Labs Scores $9.5M in Series A Funding

The platform can be used across various upper- and lower-extremity long-bone fracture applications for both adult and pediatric patients.

Core offerings include:

• Flexible nitinol intramedullary implants
• Fracture fixation systems
• Single-use orthopedic devices
• Solutions for long-bone fractures

Core Technologies / Products / Services